Next Article in Journal
Microbial Surfactants: The Next Generation Multifunctional Biomolecules for Applications in the Petroleum Industry and Its Associated Environmental Remediation
Next Article in Special Issue
Structural and Functional Dynamics of Staphylococcus aureus Biofilms and Biofilm Matrix Proteins on Different Clinical Materials
Previous Article in Journal
Hyper-Aerotolerant Campylobacter coli from Duck Sources and Its Potential Threat to Public Health: Virulence, Antimicrobial Resistance, and Genetic Relatedness
Previous Article in Special Issue
Cell-Wall Hydrolases as Antimicrobials against Staphylococcus Species: Focus on Sle1
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Staphylococcus arlettae Genomics: Novel Insights on Candidate Antibiotic Resistance and Virulence Genes in an Emerging Opportunistic Pathogen

1
Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari “Aldo Moro”, 70126 Bari, Italy
2
Department of Biosciences, University of Milan, 20133 Milan, Italy
3
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council, 70126 Bari, Italy
4
Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, 70124 Bari, Italy
5
U.O.C. Hospital-University Analysis Laboratory-U.O.S.D. Microbiology and Virology-OO. RR., 71122 Foggia, Italy
6
Department of Biology, University of Bari Aldo Moro, 70126 Bari, Italy
*
Author to whom correspondence should be addressed.
Microorganisms 2019, 7(11), 580; https://doi.org/10.3390/microorganisms7110580
Submission received: 30 October 2019 / Revised: 13 November 2019 / Accepted: 14 November 2019 / Published: 19 November 2019
(This article belongs to the Special Issue Biology and Pathogenesis of Staphylococcus Infection)

Abstract

:
Coagulase Negative Staphylococci (CoNS) are becoming increasingly recognized as an important cause of human and animal infections. Notwithstanding their clinical relevance, annotation of genes potentially involved in pathogenicity and/or antibiotic resistance in the CoNS species Staphylococcus arlettae (SAR) is currently very limited. In the current work we describe the genome of a novel methicillin resistant isolate of SAR, which we named Bari, and present a comprehensive analysis of predicted antibiotic resistance profiles and virulence determinants for all the 22 currently available SAR genomes. By comparing predicted antibiotic resistance and virulence-associated genes with those obtained from a manual selection of 148 bacterial strains belonging to 14 different species of staphylococci and to two “outgroup” species, Bacillus subtilis (BS) and Macrococcus caseoliticus (MC), we derived some interesting observations concerning the types and number of antibiotic resistance-related and virulence-like genes in SAR. Interestingly, almost 50% of the putative antibiotic resistance determinants identified in this work, which include the clinically relevant mec, van, and cls genes, were shared among all the SAR strains herein considered (Bari included). Moreover, comparison of predicted antibiotic resistance profiles suggest that SAR is closely related to well-known pathogenic Staphylococcus species, such as Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE). A similar analysis of predicted virulence factors, revealed that several genes associated with pathogenesis (including, for example, ica, nuc, and ssp), which are commonly found in the genomes of pathogenic staphylococci such as Staphylococcus haemolyticus (SH) and Staphylococcus saprophyticus (SS), are observed also in the SAR strains for which a genomic sequence is available. All in all, we believe that the analyses presented in the current study, by providing a consistent and comprehensive annotation of virulence and antibiotic resistance-related genes in SAR, can constitute a valuable resource for the study of molecular mechanisms of opportunistic pathogenicity in this species.

1. Introduction

The first strains of Staphylococcus arlettae (SAR) were reported in 1984, isolated from the skin and nares of poultry and goats [1]. Since then, SAR strains have been isolated from different animals (mainly mammals and birds) and environments including salt mines, estuaries, fermented foods, and biological safety cabinets [2,3,4,5,6]. Although SAR is normally considered a commensal species, it may also be associated to different types of infections or in contexts where a large use of antibiotics is applied. For example, SAR strains were isolated from bovine mastitis, pig exudative epidermidis, dairy goat intramammary infection, a human patient affected by rheumatic mitral stenosis, as well as from blood clinical samples [7,8,9]. Recently a plasmid encoding for nine antibiotic resistance genes, cfr, erm(C), tet(L), erm(T), aadD, fosD, fexB, aacA-aphD, and erm(B), was characterized in SA-01, a SAR strain isolated from a chicken farm. The plasmid contained three IS431 elements mediating intra- or inter-plasmid recombination, and was considered as a potential vector of antibiotic resistance genes with relevant implications on the effectiveness of clinical therapy based on antimicrobials [10]. More recently, an operon encoding for a novel functional β-lactamase (blaARL) was detected in SAN1670, a SAR strain isolated from bovine mastitis. Interestingly, blaARL was located in a high-mobility genomic island, suggesting its potential for mobilization and lateral gene transfer [11]. Independent studies have also identified several multidrug efflux pumps (e.g., norA) coding genes as well as other genes related to resistance to antibiotics such as chloramphenicol (e.g., fexA), tetracycline (e.g., tetL), and erythromycin (e.g., msrA, mphC) in the genomes of SAR strains isolated from chicken farm and dairy herds affected by mastitis [10,12,13]. The fosfomycin resistant fosD gene was described in a novel plasmid of the SAR SA-01 strain [10]. Since fosD-resistance genes are typically located in mobile genetic elements, they may contribute to multi-resistant traits to other staphylococci [14,15,16].
Additionally, several virulence-associated genes, including fibronectin/fibrinogen binding protein, programmed cell death toxin ydcD, hemolysin III, autolysins (atl), and genes involved in the regulation of virulence accessory factors such as agrA, agrB, agrR, agrV, and agrZ, were identified in the SAR CVD059 strain isolated from the blood of a cardiovascular disease patient [8,17,18].
Although SAR is emerging as an important opportunistic pathogen, apart from the studies discussed above, to date there is no comprehensive information on antibiotic resistance and presence/absence of virulence-associated genes for most of the 22 SAR isolates from which genomic sequences are available.
The resistance to most β-lactam antibiotics is a typical trait of many pathogenic staphylococci, collectively defined as methicillin-resistant staphylococci, and currently represents a relevant problem in clinical treatment of Staphylococcus infections. Indeed, methicillin resistance is usually associated with resistance to additional antibacterial agents, producing a multi-resistant phenotype that may further compromise the therapy [19]. However, at present, information concerning the presence/absence of β-lactam resistance genes is currently lacking for several Coagulase Negative Staphylococci (CoNS) species including SAR.
In this study, we present the draft genome of a novel SAR methicillin resistant strain, which we named Bari, isolated from a disused biological safety cabinet, and perform systematic bioinformatics predictions of antibiotic resistance and virulence-associated genes for all 22 SAR genomes available in the NCBI database. By comparing the predicted profiles with equivalent profiles obtained from a manually curated selection of 148 Staphylococcus genomes belonging to fourteen species and two distantly related groups of Firmicutes, Bacillus subtilis (BS) and Macrococcus caseolyticus (MC), we highlight for all the SAR genomes considered, the presence of several antibiotic-resistance genes and virulence determinants never reported thus far, which are commonly detected in pathogenic staphylococci.
The analyses presented in the current study, by providing a consistent and comprehensive annotation of virulence and antibiotic resistance-related genes in SAR, can constitute a valuable resource for the study of molecular mechanisms of opportunistic pathogenicity in this species.

2. Materials and Methods

2.1. Isolation and Sequencing of SAR Bari

The SAR Bari strain was isolated from a Nunc bioassay plate, containing LB (Lauria Bertani) agar supplemented with hexavalent chromate Cr (VI), after an incubation at room temperature on the top of a disused biological safety cabinet. SAR Bari exhibited a high resistance to Cr (VI), up to 150 mM in LB and M9 minimal broth. Genomic DNA was extracted with the DNeasy blood and tissue kit (Qiagen, Hilden, Germany) and sequenced by an Illumina MiSeq instrument (San Diego, CA, USA) by producing 2 × 250 nucleotide bp paired-end reads.

2.2. Genome Assembly and Taxonomic Classification of SAR Bari

Raw sequencing data from the Illumina platform were processed using a modified version of the “Fosmid1” pipeline in the A-GAME Galaxy framework [20,21]. Quality trimming was executed using the sliding-window operation in Trimmomatic with default parameters [22]. Overlapping reads were merged using PEAR with standard parameters [23]. The final assembly was performed using the SPAdes assembler (version 3.50) using kmers of 33, 55, 77, 99, and 121 nt [24]. Annotation was performed with PROKKA with default parameters [25]. The draft genome of SAR Bari was deposited in NCBI under the accession number WEIN00000000, BioSample number SAMN12991358 and BioProject number ID PRJNA576354. Taxonomic classification of SAR Bari was performed by using Tetra Correlation Search (TCS) and ANI (Average Nucleotide Identity), as implemented by the JspeciesWS web server http://jspecies.ribohost.com/jspeciesws/) [26].

2.3. Antimicrobial Susceptibility Testing

Antimicrobial susceptibility of the SAR Bari strain was determined by a BD PHOENIX 100 instrument (Becton Dickinson, Franklyn Lake, NJ). Data were elaborated by the BD Epicenter Expert System according to EUCAST rules (http://www.eucast.org). The PMIC/ID-88 (BD) panel was used to test susceptibility to ampicillin, cefoxitin, ceftaroline, ciprofloxacin, clindamycin, daptomycin, erythro-mycin, fosfomycin, fusidic acid, gentamicin, imipenem, linezolid, moxifloxacin, mupirocin, nitro-furantoin, oxacillin, penicillin, rifampin, teicoplanin, tetracyclin, tigecycline, trimethoprim/ sulfamethoxazole, and vancomycin. The Epsilometer Test (ETest) was used for testing resistance to ciprofloxacin, daptomycin, erythromycin, gentamicin, moxifloxacin, tetracyclin, tigecycline, trimethoprim/sulfamethoxazole, and vancomycin (bioMérieux, Marcy-L’Étolie, France and Liofilchem, Roseto degli Abruzzi, Italy). All tests were repeated on four independent technical replicates. MIC interpretative breakpoints were defined according to EUCAST recommendations. Staphylococcus aureus ATCC 29213 was used as a control strain.

2.4. Comparative Genomics Dataset

In order to carry out a comparative analysis of predicted profiles of antibiotic resistance and virulence-associated genes in the genus Staphylococcus, 148 strains from 14 different species of Staphylococcus (SAR included) were selected, including two distantly related species (BS and MC) to provide an outgroup for comparative analyses.
Staphylococcus species included in these analyses were selected based on the criteria previously proposed [27]. Briefly, the Staphylococcus genus was subdivided in six major sub-clades. For each sub-clade one or more representative species were selected based on the availability of genomic sequences and annotation of protein coding genes in GenBank. Only species for which genome annotation for at least four distinct strains and for which the genome sequences of the representative types of strains were available were included in the study. A total of 148 strains belonging to 16 species were selected based on these criteria. These include: 14 Staphylococcus arlettae (SAR), 13 Staphylococcus aureus (SA), 12 Staphylococcus saprophyticus (SS), 12 Staphylococcus cohnii (SC), 11 Staphylococcus epidermidis (SE), 11 Staphylococcus haemolyticus (SH), 11 Staphylococcus simulans (SSI), 11 Staphylococcus sciuri (SSC), 5 Staphylococcus kloosii (SK) 5 Staphylococcus hyicus (SHY), 5 Staphylococcus chromogenes (SCH), 5 Staphylococcus agnetis (SAG), 5 Staphylococcus felis (SF), 4 Staphylococcus auricularis (SAU), 13 Bacillus subtilis (BS), and 11 Macrococcus caseolyticus (MC). The complete list of SAR strains used in this study is reported in Table S1. All genomes deposited before June 2019 were considered. The complete list of species included in the dataset for the comparative genomics analysis, with the corresponding GenBank accession numbers, are in Table S2.

2.5. Genomics of Antibiotic Resistance

Putative antibiotic resistance genes were detected by RGI v.5.1.0 (Resistance Gene Identifier, https://card.mcmaster.ca/analyze/rgi) using the CARD (Comprehensive Antibiotic Resistance Database, https://card.mcmaster.ca/home) reference collection on the predicted annotated CDS (CoDing Sequence) for all considered species [28]. All the analyses were performed using the RGI web portal with default parameters. The RGI output was imported in Cytoscape v.3.7.2. to generate a network of shared antibiotic resistance determinants, where the distance among species was proportional to the number of unique elements detected per species and connections among species [29].

2.6. Genomics of Virulence

Prediction of virulence-associated genes was performed by VRprofile v.2.0 (http://db-mml.sjtu.edu.cn/STEP/index.php) and VFanalyzer (http://www.mgc.ac.cn/cgi-bin/VFs/v5/main.cgi?func=VFanalyzer) tools, using default parameters [30,31]. VRprofile can predict 15 different types of virulence-related elements, including Virulence Factors (VF), Acquired Antibiotic Resistance Determinants (AR), Type III secretion effectors (T3SE), Type IV secretion effectors (T4SE), Type VI secretion effectors (T6SE), Type VII secretion effectors (T7SE), Type III secretion systems (T3SS), Type VI secretion systems (T6SS), Type VII secretion systems (T7SS), Prophage, Class I Integrons, Insertion Sequence elements (IS), Pathogenicity Islands (PAI), Antibiotic Resistance Islands (ARI), and Integrative and Conjugative Elements (ICE). VFanalyzer was instead applied for the prediction of specific virulence factors (e.g., enzymes, toxins, capsule). Clustering of SAR and other species investigated based on the number of virulence-related genes per species was performed by applying PermutMatrix (version 1.9.3) [32]. The comparison of virulence elements and factors among species were carried out by the Draw Venn Diagram web resource (http://bioinformatics.psb.ugent.be/webtools/Venn).

3. Results

3.1. Genomics and Taxonomy of SAR (Staphylococcus arlettae) Bari

The final assembly of the SAR Bari strain consisted of 75 scaffolds, for a total size of 2,547,240 bp and an N50 of 90.3 Kb. A total of 2530 genes and 2460 coding sequences (CDS) were annotated. Taxonomic characterization based on TCS suggested that SAR Bari was very closely related to the SAR type strain (NCTC 12413T), with a z-score of 0.99915, which is marginally above the cut-off value for species identification. Average Nucleotide Identity (ANI) between the draft genome assembly of SAR Bari and NCTC 12413T was 98.68%, that is well above the value typically used for species delineation (95–96%). Based on this evidence, both TCS and ANI suggested the classification of the isolate as a novel SAR strain, which was then named Staphylococcus arlettae Bari.

3.2. Antibiotic Resistance of SAR Bari

The experimental results of the antimicrobial susceptibility test showed that SAR Bari was resistant to oxacillin and to all β-lactam antibiotics tested (ampicillin, cefoxitin, ceftaroline, imipenem, penicillin). Resistance to clindamycin, erythromycin, fosfomycin, and fusidic acid was also observed. SAR Bari was sensitive to ciprofloxacin, moxifloxacin, daptomycin, teicoplanin, vancomycin, tetracycline, tigecycline, gentamicin, linezolid, trimethoprim/sulfamethoxazole, mupirocin, nitrofurantoin, and rifampin. A full concordance between results obtained by the BD Phoenix and ETest was observed.
Experimental data were in line with the prediction carried out by the RGI software, which identified a total of 227 potential antibiotic resistance genes in the SAR Bari potential proteome, showing significant sequence similarity with protein sequences included in the CARD database (Table 1).
The majority of these genes were annotated as multidrug resistance proteins, however, proteins likely involved in the resistance to specific antibiotic classes such as aminoglycosides (e.g., aac(6′)-iw, aac(6′)-ie-aph(2″)-ia, spd), fluoroquinolones (e.g., gyrA, emeA), fosfomycine (e.g., murA, fosD, fosA6), glycopeptides (e.g., vanE, vanL), and tetracycline (e.g., tetT, otrA) were also observed.
The majority of candidate antibiotic resistance proteins identified by RGI were associated with efflux-based mechanisms of antibiotic resistance (52%), with other hits correlated to resistance mechanisms involving antibiotic target alteration, protection and replacement (31%), and antibiotic inactivation (17%) (Figure 1).

3.3. Antibiotic Resistance Genomics of SAR and Species Dataset

The number of putative antibiotic resistance genes identified by RGI in other SAR strains was substantially equivalent to that identified for SAR Bari (Table 2), ranging from 234 (AR15) to 212 (AR12). Consistent with our previous observations, 112–125 of these proteins were associated with efflux-based mechanisms of antibiotic resistance (Table 2).
Comparative analysis between resistomes of SAR Bari and all other SAR strains evidenced 94 shared antibiotic determinants, whereas eleven strains (SAR Bari included) were characterized by unique antibiotic determinants (Table S3). However, we noticed that the numbers of these unique determinants were consistently low (≤3) for most of the strains, with mexL; aac(6′)-34; arl-1; aac(6′)-ie-aph(2″)-ia exclusively found in SAR Bari.
The RGI analysis of antibiotic resistance determinants in the extended dataset of 148 strains detected a total of 505 distinct antibiotic resistance-like genes (Table S4) with thirty-six shared between all species investigated. Unique determinants were identified for all 16 species of the dataset. While nine genes were found to be specific to SAR isolates (catA8, fosB3, emrA, gimA, spd, tetA, fosA6, mdtH, and otrC genes), a number of SAR genes were shared exclusively with SA (imp-35 gene), BS (vanSN, qepA4, cau-1, catB9 genes), and SK (soxS, qacB genes).
Similarity of global profiles of predicted antibiotic resistance patterns are represented in the form of a network graph in Figure 2, where nodes represent species and edges represent shared predicted antibiotic resistance genes. As outlined in the figure, predicted resistome genes identified in BS are remarkably different from predicted resistome genes of other staphylococci and MC. Reduced levels of diversity are observed for SH, SS, SSC, SAU, SE, and SC, with SAR more closely related to SA, SE, SC, and SCH.

3.4. Analysis of the Distribution of Putative Virulence Elements

Prediction of virulence-associated genes in SAR Bari, carried out by VRprofile, identified a total of 440 putative virulence-related genes, showing significant levels of similarity with VF, AR, T3SE, T4SE, T6SE, T7SE, T3SS, T6SS, T7S, Prophage, Integrons, IS, PAI, and ARI virulence elements in the VFDB database (Table S5). The majority of the genes identified by the VRprofile were annotated as VF (135), ARI (66), PAI (84), Prophage (111), and AR (120), while T3SE, T4SE, T3SS, T6SS, Integrons, and IS were much less represented.
Comparative analysis did not evidence relevant differences between the virulence profile of SAR Bari and all other SAR strains (Table S6) with, for example, AR2 (657) and TSAR (644) showing a higher number of virulence elements identified with respect to other strains such as AR4 (521) or B (Bari, 542).
Clustering of virulence elements profiles performed on the 148 genomes dataset, which are represented in the heatmap in Figure 3 (data in Table S6), highlighted two major groups, one of them possibly split into four additional subgroups (G1–G4) and the other corresponding to BS. G1 and G2 include virulence profiles of SSC, SAG, SHY, SCH, SAU, SSI, SE, SH, and MC strains. G3 includes virulence profiles of SAR strains as well as other species (SC, SK, SH, and SS). In particular, SAR Bari (B) showed a high similarity with SAR B1, B2, and B3. G3 also included the SE strain (SE9). G4, well separated from the other groups, was instead represented by virulence profiles of SA strains.

3.5. Virulence Factors within SAR and Species Dataset

VFanalyzer identified a total of 23 putative virulence factors, related to five different classes (VFclass) in the genome of SAR Bari (Table 3). Most of these (14) were related to genes (capsule undetermined, capB, capC, galE) coding for virulence factors involved in immune system evasion (VFclass 2). Additional predicted virulence factors were associated with allantoine utilization (4 hits, nutritional factors); lipase (1 hit, lip), protease (1 hit, sspA), and nuclease activity (1 hit, nuc); virulence-factor-related to the process of antiphagocytosis (1 hit, uge); and serum resistance and immune evasion (1 hit, wbtP).
All the predicted virulence factors identified in SAR Bari were present in at least one of the SAR strains included in the study (Table 4).
In total, 39 distinct virulence-related genes were identified by VFanalyzer in SAR. Of these, only two genes, one related to VFclass-immune evasion (capsule undetermined) and one to the VFclass-enzyme (sspA gene related to a serine protease), were shared between all SAR strains. The groEL and lplA1 genes were found exclusively in the AR8 strain, while hemL and icaC genes were identified solely in the AR12 and AR17 strains.
Profiles of presence/absence of virulence-factor-related genes identified within SAR strains were compared with equivalent profiles derived from the analyses of the other 15 bacterial species considered in this study. The complete results of these analyses are reported in Table S7. Comparison of the presence/absence of virulence-related genes identified in SAR with the other species considered in the study are reported in Table 5. A total of 160 distinct virulence-factor-related genes were identified in the 148 genomes included in our dataset, of these, 37 were shared between SAR and different species in the dataset (Table 5). Among these, SAR shared four genes uniquely with BS (plr/gapA, katA, acpXL, and gnd), one gene with SAU (lpeA), and one gene with SE (eno). Further, SAR had six unique genes (flmH, T6SS-II, tuf, groEL, slrA, and sigA/rpoV).

4. Discussion

Despite the considerable clinical and environmental relevance of CoNS and the availability of an increasing number of genomic sequences, at present, information concerning SAR, particularly the presence/absence of putative virulence factors and antibiotic resistance genes, is limited.
In this study we present a detailed comparative genomics analysis of predicted resistomes and virulence factors of a carefully selected collection of 124 representative staphylococci, including all the currently available SAR genomes.
Our analyses highlight the presence of numerous candidate antibiotic resistance genes in SAR. Interestingly, several of these genes are commonly observed in other Staphylococcus species, suggesting a widespread presence of putative antibiotic resistance genes in the genomes of staphylococci. On the other hand, some genes (e.g., fosB3 and tetA) are consistently observed only in SAR isolates, or are shared between SAR and a limited number of commensal (soxS with SK) and pathogenic species (e.g., imp-35 and catB9 with SA and BS, respectively).
The global analysis of predicted antibiotic resistance profiles, as shown in Figure 2, clearly indicated that the predicted resistome of SAR is closely related to the predicted resistomes of pathogenic species, including SE and SA.
Notably, we observe that the predicted antibiotic resistance profile of MC, which was included in our analyses to serve as a reasonably phylogenetically distant outgroup, was very closely related to that of several Staphylococcus species, suggesting that these bacteria have very similar antibiotic resistance profiles. This observation might reflect that Macrococcus and Staphylococcus can be found associated in different environments (e.g., animal infections, milk, meat products) were horizontal gene transfer could take place [33].
However, the observation that Macrococcus and Staphylococcus are very closely related from a phylogenetic point of view could provide an equally likely explanation [34]. Importantly, predicted antibiotic resistance profiles recovered for BS, which in this study was used as an alternative outgroup species, were considerably different from those of staphylococcal genomes.
All the SAR strains herein considered contained a similar number of predicted antibiotic resistance genes. Unsurprisingly these genes were consistently annotated to similar functional classes. The majority (~50%) of putative antibiotic resistance genes identified in SAR strains were consistently associated with the efflux-based mechanism of resistance (Table 2). In this respect, it should be noted that several recent studies suggest an increasing relevance of efflux pumps in antibiotic resistance mechanisms [35]. Efflux pumps displayed a tendency to promote loss of substrate specificity, which could translate into multi-resistance [36,37]. Moreover, as evidenced in a recent large-scale genomics investigation of pathogenicity determinants, many efflux pumps do not exclusively export antimicrobials, but could be implicated in bacterial virulence, representing potent targets for adaptation to a pathogenic lifestyle [38,39].
Our genomic analysis also predicted some genes of clinical relevance for all SAR strains. These include methicillin resistance (mecD, mecR1, and mecI), vancomycin resistance (e.g., vanKI, vanHA, vanTG, and vanYM) as well as daptomycin resistance (cls, rpoB, and pgsA). Moreover, the SAR Bari strain, which was described and characterized for the first time in this study, contained a putative arl-1 gene encoding for a novel β-lactamase, which was recently identified by whole-genome sequencing of a penicillin-resistant SAR strain (SAN1670) [11]. Interestingly, this gene was observed only in the SAN1670 and Bari strains, while all the other SAR strains and Staphylococcus species considered in this study contained the blaZ gene, coding for the most common β-lactamase found in staphylococci.
Notwithstanding these very interesting considerations, we observe that the predicted profile of antibiotic resistance of the SAR Bari strain does not completely match the experimental data obtained in this study. Indeed, while we observe a perfect correspondence between candidate resistance genes and in vitro resistance to several antibiotics (e.g., all used β-lactam antibiotics, fosfomycin, fusidic acid, erythromycin), it is also true that SAR Bari was sensitive to some antimicrobials (e.g., tetracycline, gentamicin, teicoplanin) for which putative resistance genes were predicted. These observations could be explained by several possible reasons, including complex regulatory mechanisms of gene expression, reduced enzymatic activity of some predicted candidate genes, or involvement of these genes in the resistance to other types of antimicrobials. Notwithstanding these limitations, we believe that the availability of a large and comprehensive annotation of candidate antimicrobial resistance genes in CoNS will constitute an important resource for the functional characterization of these genes and a more detailed understanding of the molecular mechanisms involved in antibiotic resistance.
Bioinformatics prediction of virulence-related genes identified a consistent number of putative virulence elements and factors (Table 5 and Table S6) in the genomes of all the SAR strains. Comparative analyses suggested that the predicted virulence profiles of SAR isolates have a relevant similarity with other pathogenic staphylococci, including SS and SH (Figure 3, Table S6).
These observations are confirmed even when a specific set of virulence factors (e.g., ssp, nuc, cap) involved in immune evasion is considered.
Remarkably, the putative orthologs of the ssp, nuc, and cap, which have recently been described in the majority of opportunistic CoNS pathogenic species (SE, SH, and SS), were observed in all SAR strains for which genomic sequences are available [40].
The presence of a high number of predicted antibiotic resistance genes and virulence-related elements in SAR suggests that these genes might constitute an important genetic reservoir of genes of clinical relevance for other pathogenic bacterial strains and species.
In conclusion, we believe that by providing, for the first time, an extensive annotation of potentially clinically relevant pathogenic genes in SAR isolates, the analyses here presented can constitute a valuable resource for the study of molecular mechanisms of opportunistic pathogenicity in this species and the functional characterization of antibiotic resistance and virulence genes of CoNS in general.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-2607/7/11/580/s1, Table S1: Genome assembly of Staphylococcus arlettae, Table S2: DATASET: Species and Genome Assembly, Table S3: Antibiotic resistance determinants within SAR, Table S4: Antibiotic resistance determinants shared among SAR and other species in the dataset, Table S5: Virulence elements of the SAR Bari draft genome, Table S6: Number of predicted genes correlated to virulence elements identified within species in the dataset, Table S7: Distribution of putative genes related to virulence factors identified within species in the dataset.

Author Contributions

Conceptualization, A.L. and A.P.; DNA sequencing and assembling, C.M.; M.C.; D.H.; Culture and Isolation, A.P., C.D.V.; C.P.; Antimicrobial assays, R.M.; A.D.C.; Bioinformatics analysis, A.L.; M.C.; original draft preparation, A.L.; A.P.; C.D.V.; writing—review and editing, A.L.; A.P.; G.P.; supervision, A.P.; G.P.; funding acquisition, G.P.

Funding

This work was supported by INMARE (H2020-BG-2014-2, GA 634486), EMBRIC (H2020-INFRADEV-1-2014-1, GA 654008), EXCELERATE (H2020-INFRADEV-1-2015-1, GA676559), the Molecular Biodiversity Laboratory (Life Watch, Italy), and the Italian Node of ELIXIR. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Schleifer, K.H.; Kilpper-Bälz, R.; Devriese, L.A. Staphylococcus arlettae sp. nov., S. equorum sp. nov. and S. k1oosii sp. nov.: Three New Coagulase-Negative, Novobiocin-Resistant Species from Animals. Syst. Appl. Microbiol. 1984, 5, 501–509. [Google Scholar] [CrossRef]
  2. Adkins, P.R.F.; Dufour, S.; Spain, J.N.; Calcutt, M.J.; Reilly, T.J.; Stewart, G.C.; Middleton, J.R. Cross-sectional study to identify staphylococcal species isolated from teat and inguinal skin of different-aged dairy heifers. J. Dairy Sci. 2018, 101, 3213–3225. [Google Scholar] [CrossRef]
  3. Chauhan, M.; Garlapati, V.K. Production and Characterization of a Halo-, Solvent-, Thermo-tolerant Alkaline Lipase by Staphylococcus arlettae JPBW-1, Isolated from Rock Salt Mine. Appl. Biochem. Biotechnol. 2013, 171, 1429–1443. [Google Scholar] [CrossRef]
  4. Pereira, E.J.; Ramaiah, N. Chromate detoxification potential of Staphylococcus sp. isolates from an estuary. Ecotoxicol. Lond. Engl. 2019, 28, 457–466. [Google Scholar] [CrossRef]
  5. Tu, R.-J.; Wu, H.-Y.; Lock, Y.-S.; Chen, M.-J. Evaluation of microbial dynamics during the ripening of a traditional Taiwanese naturally fermented ham. Food Microbiol. 2010, 27, 460–467. [Google Scholar] [CrossRef]
  6. Lavecchia, A.; Chiara, M.; Manzari, C.; Trotta, M.; Marzano, M.; Horner, D.; Pesole, G.; Placido, A. Draft Genome Sequences of Three Novel Staphylococcus arlettae Strains Isolated from a Disused Biological Safety Cabinet. Microbiol. Resour. Announc. 2018, 7. [Google Scholar] [CrossRef]
  7. Park, J.; Friendship, R.M.; Weese, J.S.; Poljak, Z.; Dewey, C.E. An investigation of resistance to β-lactam antimicrobials among staphylococci isolated from pigs with exudative epidermitis. BMC Vet. Res. 2013, 9, 211. [Google Scholar] [CrossRef]
  8. Dinakaran, V.; Shankar, M.; Jayashree, S.; Rathinavel, A.; Gunasekaran, P.; Rajendhran, J. Genome sequence of Staphylococcus arlettae strain CVD059, isolated from the blood of a cardiovascular disease patient. J. Bacteriol. 2012, 194, 6615–6616. [Google Scholar] [CrossRef]
  9. Bernier Gosselin, V.; Dufour, S.; Adkins, P.R.F.; Middleton, J.R. Persistence of coagulase negative staphylococcal intramammary infections in dairy goats. J. Dairy Res. 2019, 86, 211–216. [Google Scholar] [CrossRef]
  10. Liu, B.-H.; Lei, C.-W.; Zhang, A.-Y.; Pan, Y.; Kong, L.-H.; Xiang, R.; Wang, Y.-X.; Yang, Y.-X.; Wang, H.-N. Colocation of the Multiresistance Gene cfr and the Fosfomycin Resistance Gene fosD on a Novel Plasmid in Staphylococcus arlettae from a Chicken Farm. Antimicrob. Agents Chemother. 2017, 61. [Google Scholar] [CrossRef]
  11. Andreis, S.N.; Perreten, V.; Schwendener, S. Novel β-Lactamase blaARL in Staphylococcus arlettae. mSphere 2017, 2, e00117-17. [Google Scholar] [CrossRef] [PubMed]
  12. Nobrega, D.B.; Naushad, S.; Naqvi, S.A.; Condas, L.A.Z.; Saini, V.; Kastelic, J.P.; Luby, C.; De Buck, J.; Barkema, H.W. Prevalence and Genetic Basis of Antimicrobial Resistance in Non-aureus Staphylococci Isolated from Canadian Dairy Herds. Front. Microbiol. 2018, 9, 256. [Google Scholar] [CrossRef]
  13. Xu, J.; Tan, X.; Zhang, X.; Xia, X.; Sun, H. The diversities of staphylococcal species, virulence and antibiotic resistance genes in the subclinical mastitis milk from a single Chinese cow herd. Microb. Pathog. 2015, 88, 29–38. [Google Scholar] [CrossRef] [PubMed]
  14. Qu, T.-T.; Yang, Q.; Shen, P.; Wei, Z.-Q.; Yu, Y.-S. Novel Vancomycin-Resistance Transposon, Plasmid Replicon Types, and Virulence Factors of Vancomycin-Resistant Enterococci in Zhejiang, China. Microb. Drug Resist. 2012, 18, 183–188. [Google Scholar] [CrossRef]
  15. Xu, X.; Chen, C.; Lin, D.; Guo, Q.; Hu, F.; Zhu, D.; Li, G.; Wang, M. The Fosfomycin Resistance Gene fosB3 Is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus faecium Isolates. PLoS ONE 2013, 8, e78106. [Google Scholar] [CrossRef]
  16. Schnabel, E.L.; Jones, A.L. Distribution of Tetracycline Resistance Genes and Transposons among Phylloplane Bacteria in Michigan Apple Orchards. Appl. Environ. Microbiol. 1999, 65, 4898–4907. [Google Scholar]
  17. Li, M.; Guan, M.; Jiang, X.F.; Yuan, F.Y.; Xu, M.; Zhang, W.Z.; Lu, Y. Genetic polymorphism of the accessory gene regulator (agr) locus in Staphylococcus epidermidis and its association with pathogenicity. J. Med. Microbiol. 2004, 53, 545–549. [Google Scholar] [CrossRef]
  18. Vandenesch, F.; Projan, S.J.; Kreiswirth, B.; Etienne, J.; Novick, R.P. Agr-related sequences in Staphylococcus lugdunensis. FEMS Microbiol. Lett. 1993, 111, 115–122. [Google Scholar] [CrossRef]
  19. Choo, E.J.; Chambers, H.F. Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Infect. Chemother. 2016, 48, 267–273. [Google Scholar] [CrossRef]
  20. Chiara, M.; Placido, A.; Picardi, E.; Ceci, L.R.; Horner, D.S.; Pesole, G. A-GAME: Improving the assembly of pooled functional metagenomics sequence data. BMC Genom. 2018, 19, 44. [Google Scholar] [CrossRef]
  21. Afgan, E.; Baker, D.; Batut, B.; van den Beek, M.; Bouvier, D.; Čech, M.; Chilton, J.; Clements, D.; Coraor, N.; Grüning, B.A.; et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018, 46, W537–W544. [Google Scholar] [CrossRef]
  22. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinform. Oxf. Engl. 2014, 30, 2114–2120. [Google Scholar] [CrossRef]
  23. Zhang, J.; Kobert, K.; Flouri, T.; Stamatakis, A. PEAR: A fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 2014, 30, 614–620. [Google Scholar] [CrossRef]
  24. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef]
  25. Seemann, T. Prokka: Rapid prokaryotic genome annotation. Bioinformatics 2014, 30, 2068–2069. [Google Scholar] [CrossRef]
  26. Richter, M.; Rosselló-Móra, R. Shifting the genomic gold standard for the prokaryotic species definition. Proc. Natl. Acad. Sci. USA 2009, 106, 19126–19131. [Google Scholar] [CrossRef]
  27. Lamers, R.P.; Muthukrishnan, G.; Castoe, T.A.; Tafur, S.; Cole, A.M.; Parkinson, C.L. Phylogenetic relationships among Staphylococcus species and refinement of cluster groups based on multilocus data. BMC Evol. Biol. 2012, 12, 171. [Google Scholar] [CrossRef]
  28. Jia, B.; Raphenya, A.R.; Alcock, B.; Waglechner, N.; Guo, P.; Tsang, K.K.; Lago, B.A.; Dave, B.M.; Pereira, S.; Sharma, A.N.; et al. CARD 2017: Expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2017, 45, D566–D573. [Google Scholar] [CrossRef]
  29. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef]
  30. Li, J.; Tai, C.; Deng, Z.; Zhong, W.; He, Y.; Ou, H.-Y. VRprofile: Gene-cluster-detection-based profiling of virulence and antibiotic resistance traits encoded within genome sequences of pathogenic bacteria. Brief. Bioinform. 2018, 19, 566–574. [Google Scholar] [CrossRef]
  31. Liu, B.; Zheng, D.; Jin, Q.; Chen, L.; Yang, J. VFDB 2019: A Comparative Pathogenomic Platform with an Interactive Web Interface. Nucleic Acids Res. 2019, 47, D687–D692. [Google Scholar] [CrossRef]
  32. Caraux, G.; Pinloche, S. PermutMatrix: A graphical environment to arrange gene expression profiles in optimal linear order. Bioinform. Oxf. Engl. 2005, 21, 1280–1281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Mašlaňová, I.; Wertheimer, Z.; Sedláček, I.; Švec, P.; Indráková, A.; Kovařovic, V.; Schumann, P.; Spröer, C.; Králová, S.; Šedo, O.; et al. Description and Comparative Genomics of Macrococcus caseolyticus subsp. hominis subsp. nov., Macrococcus goetzii sp. nov., Macrococcus epidermidis sp. nov., and Macrococcus bohemicus sp. nov., Novel Macrococci From Human Clinical Material With Virulence Potential and Suspected Uptake of Foreign DNA by Natural Transformation. Front. Microbiol. 2018, 9, 1178. [Google Scholar] [CrossRef] [PubMed]
  34. Mazhar, S.; Hill, C.; McAuliffe, O. The Genus Macrococcus: An Insight into Its Biology, Evolution, and Relationship With Staphylococcus. Adv. Appl. Microbiol. 2018, 105, 1–50. [Google Scholar] [CrossRef]
  35. Alcalde-Rico, M.; Hernando-Amado, S.; Blanco, P.; Martínez, J.L. Multidrug Efflux Pumps at the Crossroad between Antibiotic Resistance and Bacterial Virulence. Front. Microbiol. 2016, 7, 1483. [Google Scholar] [CrossRef] [Green Version]
  36. Lewis, K. Multidrug resistance pumps in bacteria: Variations on a theme. Trends Biochem. Sci. 1994, 19, 119–123. [Google Scholar] [CrossRef]
  37. Vargiu, A.V.; Pos, K.M.; Poole, K.; Nikaido, H. Editorial: Bad Bugs in the XXIst Century: Resistance Mediated by Multi-Drug Efflux Pumps in Gram-Negative Bacteria. Front. Microbiol. 2016, 7, 833. [Google Scholar] [CrossRef] [Green Version]
  38. Brambila-Tapia, A.J.L.; Armenta-Medina, D.; Rivera-Gomez, N.; Perez-Rueda, E. Main Functions and Taxonomic Distribution of Virulence Genes in Brucella melitensis 16 M. PLoS ONE 2014, 9, e100349. [Google Scholar] [CrossRef] [Green Version]
  39. Jeukens, J.; Freschi, L.; Vincent, A.T.; Emond-Rheault, J.-G.; Kukavica-Ibrulj, I.; Charette, S.J.; Levesque, R.C. A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter. Genome Biol. Evol. 2017, 9, 1030–1046. [Google Scholar] [CrossRef]
  40. Argemi, X.; Hansmann, Y.; Prola, K.; Prévost, G. Coagulase-Negative Staphylococci Pathogenomics. Int. J. Mol. Sci. 2019, 20, 1215. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Pie chart of molecular determinants involved in antibiotic resistance mechanisms of SAR Bari draft genome.
Figure 1. Pie chart of molecular determinants involved in antibiotic resistance mechanisms of SAR Bari draft genome.
Microorganisms 07 00580 g001
Figure 2. Network of antibiotic resistance determinants shared between all investigated species. Network was built by Cytoscape v. 3.7.2. The distance between species is proportional to the number of unique elements per species and connections among species. Orange diamond, SAR; yellow diamonds, Staphylococcus species (SA, SE, SAU, SSI, SSC, SCH, SC, SHY, SS, SAG, SK, SH, SF); light blue diamonds, outgroup species (BS, MC). The size of each diamond corresponds to the number of antibiotic resistance determinants per species. See Table S4 for details on the molecular elements of antibiotic resistance shared among the species in the dataset. Species abbreviations are in the Material and Methods Section (Section 2.4).
Figure 2. Network of antibiotic resistance determinants shared between all investigated species. Network was built by Cytoscape v. 3.7.2. The distance between species is proportional to the number of unique elements per species and connections among species. Orange diamond, SAR; yellow diamonds, Staphylococcus species (SA, SE, SAU, SSI, SSC, SCH, SC, SHY, SS, SAG, SK, SH, SF); light blue diamonds, outgroup species (BS, MC). The size of each diamond corresponds to the number of antibiotic resistance determinants per species. See Table S4 for details on the molecular elements of antibiotic resistance shared among the species in the dataset. Species abbreviations are in the Material and Methods Section (Section 2.4).
Microorganisms 07 00580 g002
Figure 3. Heatmap of virulence elements detected in the dataset. Clustering was based on comparative quantitative analysis of similar virulence elements identified within 148 genomes of the dataset. The different groups represent five different sets of virulence profiles. Color scale corresponds to the number of predicted genes associated to specific virulence element, from green (lowest) to red (highest). Note: Abbreviations used are relative to single strains (see Table S2 for details).
Figure 3. Heatmap of virulence elements detected in the dataset. Clustering was based on comparative quantitative analysis of similar virulence elements identified within 148 genomes of the dataset. The different groups represent five different sets of virulence profiles. Color scale corresponds to the number of predicted genes associated to specific virulence element, from green (lowest) to red (highest). Note: Abbreviations used are relative to single strains (see Table S2 for details).
Microorganisms 07 00580 g003
Table 1. In vitro antibiotic susceptibility of Staphylococcus arlettae (SAR) Bari and correlated predicted genes.
Table 1. In vitro antibiotic susceptibility of Staphylococcus arlettae (SAR) Bari and correlated predicted genes.
Drug ClassAntibiotic TestedIn Vitro SusceptibilityPredicted Genes
1.β-LactamOxacillinRampS, ampC, gob-2, gob-18, imp-35, arl-1, nmcA, nmcR, mecD, mecI, mecR1
2.AmpicillinR
3.CefoxitinR
4.CeftarolineR
5.ImipenemR
6.PenicillinR
7.LincosamideClindamycinRermC, ermK, cfrC, oleC, mexL, mexS
8.MacrolideErythromycinR
9.-FosfomycinRfosD, fosB5, fosA6, fosB2
10.Fusidic AcidFusidic AcidRfusA
11.FluoroquinoloneCiprofloxacinSgyrA, gyrB, norA, norB, pmrA, patA, arlS, arlR
12.MoxifloxacinS
13.PeptideDaptomycinScls, pgsA, mprf
14.GlycopeptideTeicoplaninS-
15.VancomycinSvanKI, vanK, vanTG, vanHM, vanH, vanT, vanL
16.TetracyclineTetracyclineSemrA, emrB, emrY, emrR, tet(X3), tetT, tet35, tet47, adeN, adeL, adeR,
17.TigecyclineS
18.AminoglycosideGentamicinSaac(6′), aph(2″), mexS, mexL, acrS
19.OxazolidinoneLinezolidScfrB, cfrC, lmrS, poxtA
20.Diaminopyrimidine-SulfonamideTrimethoprim-SulfamethoxazoleSdfr
21.Monoxycarbolic AcidMupirocinSmup, ileS
22.NitrofuranNitrofurantoinS-
23.RifamycinRifampinSrpoB2
Table 2. Number of potential antibiotic resistance genes involved in antibiotic resistance mechanisms detected for each SAR strain after querying the Comprehensive Antibiotic Resistance Database (CARD).
Table 2. Number of potential antibiotic resistance genes involved in antibiotic resistance mechanisms detected for each SAR strain after querying the Comprehensive Antibiotic Resistance Database (CARD).
Strain *NAntibiotic EffluxAntibiotic InactivationAntibiotic Target AlterationAntibiotic Target ProtectionAntibiotic Target Replacement
B2271173957104
TS2271193755115
B12241173553145
B22191163351145
B32151162952135
AR1219113325996
AR22151143054125
AR32201143356125
AR42251203454125
AR52161133254125
AR62151123057115
AR72201133258125
AR82201143356125
AR92231163556115
AR102281183458135
AR112251193257125
AR122121133053115
AR132191123159125
AR142151133353115
AR152341253557125
AR162221153555125
AR17217114355585
AR182181143355106
* B, SAR Bari strain; other abbreviations used are relative to the SAR genomes publicly available in the NCBI (see Table S1 for details).
Table 3. Virulence factors encoded by SAR Bari draft genome *.
Table 3. Virulence factors encoded by SAR Bari draft genome *.
VfclassVirulence FactorsRelated GenesHits
1-EnzymesLipaselipPROKKA_00412
Serine V8 proteasesspAPROKKA_02492
ThermonucleasenucPROKKA_01673
2-Immune evasionCapsuleundeterminedPROKKA_00763; PROKKA_01266; PROKKA_01584; PROKKA_02340; PROKKA_02341; PROKKA_02342; PROKKA_02343; PROKKA_02439; PROKKA_02440; PROKKA_02511;
Capsule (Acinetobacter)-PROKKA_02505
Polyglutamic acid capsule (Bacillus)capBPROKKA_01886
capCPROKKA_01887
Polysaccharide capsule (Bacillus)galEPROKKA_01613
3-AntiphagocytosisCapsule (Klebsiella)ugePROKKA_02504
4-Nutritional factorAllantoin utilization (Klebsiella)-PROKKA_00370
PROKKA_00367
PROKKA_00364; PROKKA_00365
5-Serum resistance and immune evasionLPS (Francisella)wbtPPROKKA_02442
* VFanalyzer original output.
Table 4. Virulence-factor genes predicted within SAR.
Table 4. Virulence-factor genes predicted within SAR.
Strains *.NGenes
B1; B2; B3; AR1; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B2Undetermined capsule, sspA
B1; B2; B3; AR1; AR10; AR11; AR12; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B1lip
B1; B2; B3; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; TS; B1nuc
B1; B2; B3; AR1; AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; B3capC, capB, galE
AR1; AR10; AR11; AR13; AR14; AR15; AR16; AR17; AR18; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR9; B1wbtP
AR10; AR11; AR12; AR13; AR14; AR15; AR16; AR2; AR3; AR4; AR5; AR6; AR7; AR8; AR96esaB, esaA, esBA, ess, essC, essA
B2; AR10; AR13; AR3; AR7; AR8; AR91lspA
B2; AR12; AR13; AR18; AR7; AR81gtaB
AR12; AR13; AR7; AR82tuf, katA
B1; B2; B31vctC
B2; AR12; AR85plr/gapA, ndk, eno, acpBL, flmH
B2; AR13; AR82lgt, lpeA
AR1; AR15; AR81cylR2
AR12; AR13; AR81slrA
AR17; B1uge
B1; AR172icaB, icaA
B2; AR81lisR
B2; AR121gnd
B2; AR131sigA/rpoV
B3; B1Allantoin utilization
AR82groEL, lplA1
AR121hemL
AR171icaC
* B, SAR Bari strain; other abbreviations used are relative to the SAR genomes publicly available in the NCBI (see Table S1 for details).
Table 5. Genes encoding virulence factors shared between SAR and other species in the dataset.
Table 5. Genes encoding virulence factors shared between SAR and other species in the dataset.
Species *NGenes
BS; MC; SA; SAG; SAR; SAU; SC; SCH; SE; SF; SH; SHY; SK; SS; SSC; SSI1Capsule Undetermined
SAG; SAR; SAU; SC; SCH; SE; SF; SH; SHY; SK; SS; SSI1nuc
BS; SAG; SAR; SAU; SC; SCH; SE; SH; SHY; SK; SS; SSI2capB; capC
BS; MC; SAG; SAR; SC; SCH; SE; SF; SHY; SK; SS1vctC
SA; SAR; SC; SCH; SE; SF; SH; SK; SS1lip
MC; SA; SAR; SC; SE; SK; SS; SSC; SSI1icaA
BS; MC; SAG; SAR; SCH; SF; SHY; SS; SSC1lgt
BS; SAR; SAU; SC; SF; SHY; SK; SS; SSI1galE
SA; SAR; SC; SE; SK; SS; SSC; SSI1icaB
MC; SAG; SAR; SC; SH; SHY; SK; SSI1wbtP
BS; SA; SAG; SAR; SE; SHY; SSI1essC
SA; SAR; SC; SE; SK; SS; SSC1sspA
MC; SAR; SAU; SC; SF; SH; SSI1cylR2
SA; SAG; SAR; SE; SHY; SSI3esaB; essB; esxA
MC; SAG; SAR; SCH; SHY; SSC1lisR
BS; SAG; SAR; SHY; SK; SSI1lspA
MC; SAR; SC; SH; SHY; SSI1uge
BS; SAR; SH; SHY; SK; SSI1Capsule (Acinetobacter)
SA; SAG; SAR; SE; SSI1esaA
SAR; SC; SHY; SSC; SSI1Allantoin utilization (Klebsiella)
BS; MC; SAR; SF; SS1gtaB
MC; SAR; SC; SSI1LPS O-antigen (P. aeruginosa)
BS; MC; SAR; SSC1ndk
SA; SAR; SE1essA
BS; SAR; SAU1Capsule (Enterococcus)
BS; SAR; SK1LPS rfb locus (Klebsiella)
BS; MC; SAR1lplA1
SAR; SAU1lpeA
SAR; SE1eno
BS; SAR4plr/gapA; katA; acpXL; gnd
SAR6flmH; T6SS-II(Klebsiella); tuf; groEL; slrA; sigA/rpoV
* Meanings of the abbreviations used are available in the Material and Methods (Section 2.4 Dataset). The complete list of all genes shared among all species in the dataset is available in Table S7.

Share and Cite

MDPI and ACS Style

Lavecchia, A.; Chiara, M.; De Virgilio, C.; Manzari, C.; Monno, R.; De Carlo, A.; Pazzani, C.; Horner, D.; Pesole, G.; Placido, A. Staphylococcus arlettae Genomics: Novel Insights on Candidate Antibiotic Resistance and Virulence Genes in an Emerging Opportunistic Pathogen. Microorganisms 2019, 7, 580. https://doi.org/10.3390/microorganisms7110580

AMA Style

Lavecchia A, Chiara M, De Virgilio C, Manzari C, Monno R, De Carlo A, Pazzani C, Horner D, Pesole G, Placido A. Staphylococcus arlettae Genomics: Novel Insights on Candidate Antibiotic Resistance and Virulence Genes in an Emerging Opportunistic Pathogen. Microorganisms. 2019; 7(11):580. https://doi.org/10.3390/microorganisms7110580

Chicago/Turabian Style

Lavecchia, Anna, Matteo Chiara, Caterina De Virgilio, Caterina Manzari, Rosa Monno, Armando De Carlo, Carlo Pazzani, David Horner, Graziano Pesole, and Antonio Placido. 2019. "Staphylococcus arlettae Genomics: Novel Insights on Candidate Antibiotic Resistance and Virulence Genes in an Emerging Opportunistic Pathogen" Microorganisms 7, no. 11: 580. https://doi.org/10.3390/microorganisms7110580

APA Style

Lavecchia, A., Chiara, M., De Virgilio, C., Manzari, C., Monno, R., De Carlo, A., Pazzani, C., Horner, D., Pesole, G., & Placido, A. (2019). Staphylococcus arlettae Genomics: Novel Insights on Candidate Antibiotic Resistance and Virulence Genes in an Emerging Opportunistic Pathogen. Microorganisms, 7(11), 580. https://doi.org/10.3390/microorganisms7110580

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop